Zoetis (ZTS) Asset Writedowns and Impairment (2016 - 2025)
Zoetis (ZTS) has disclosed Asset Writedowns and Impairment for 13 consecutive years, with -$5.0 million as the latest value for Q4 2025.
- On a quarterly basis, Asset Writedowns and Impairment fell 119.23% to -$5.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $47.0 million, a 51.55% decrease, with the full-year FY2025 number at $47.0 million, down 51.55% from a year prior.
- Asset Writedowns and Impairment was -$5.0 million for Q4 2025 at Zoetis, down from $19.0 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $46.0 million in Q2 2023 to a low of -$20.0 million in Q3 2023.
- A 5-year average of $14.5 million and a median of $16.0 million in 2021 define the central range for Asset Writedowns and Impairment.
- Peak YoY movement for Asset Writedowns and Impairment: surged 400.0% in 2022, then crashed 211.11% in 2023.
- Zoetis' Asset Writedowns and Impairment stood at $28.0 million in 2021, then plummeted by 85.71% to $4.0 million in 2022, then surged by 375.0% to $19.0 million in 2023, then skyrocketed by 36.84% to $26.0 million in 2024, then plummeted by 119.23% to -$5.0 million in 2025.
- Per Business Quant, the three most recent readings for ZTS's Asset Writedowns and Impairment are -$5.0 million (Q4 2025), $19.0 million (Q3 2025), and $31.0 million (Q2 2025).